MYC and small cell lung carcinoma: To determine the effects of BCL2 family inhibition in vivo, we evaluated the efficacy of BCL2 inhibitor venetoclax and MCL1 inhibitor S63845 in an Myc-driven SCLC mouse model (RPM)6.